Genetron Holdings Ltd.
(NASDAQ : GTH)

( )
GTH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
OSHOak Street Health, Inc. 4.46%46.230.0%$109.93m
DVADaVita, Inc. -0.95%81.683.2%$68.92m
GHGuardant Health, Inc. 3.07%89.420.0%$68.89m
NVTAInvitae Corp. 4.00%30.951.9%$68.33m
ONEM1Life Healthcare, Inc. 9.05%30.140.0%$63.67m
AMEDAmedisys, Inc. 1.14%231.1711.5%$46.17m
LHCGLHC Group, Inc. -0.12%195.962.9%$45.28m
NTRANatera, Inc. 5.40%56.381.3%$36.48m
OTRKOntrak, Inc. 6.21%48.260.0%$34.20m
CHEChemed Corp. -0.13%508.3410.1%$33.59m
SDCSmileDirectClub, Inc. -15.88%7.840.0%$30.94m
NEONeoGenomics, Inc. 0.78%40.275.7%$28.07m
BIOCBiocept, Inc. -0.98%1.013.0%$27.99m
FLGTFulgent Genetics, Inc. 10.93%46.180.8%$27.37m
OPCHOption Care Health, Inc. 2.13%12.460.0%$16.12m

Company Profile

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.